ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries.

CONCLUSIONS: These data reinforce the largely appropriate use of edoxaban in routine clinical practice, where the study population differs from those in prior randomised controlled trials. CLINICALTRIALS.
GOV IDENTIFIER: NCT02943993.
PMID: 32826158 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - August 17, 2020 Category: Internal Medicine Authors: Cohen AT, Hoffmann U, Hainaut P, Gaine S, Ay C, Coppens M, Schindewolf M, Jimenez D, Brüggenjürgen B, Levy P, Laeis P, Fronk EM, Zierhut W, Malzer T, Manu MC, Reimitz PE, Bramlage P, Agnelli G, ETNA-VTE-Europe investigators Tags: Eur J Intern Med Source Type: research